🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
52Score
DipBuster Score™
$72.97
+$0.11 (+0.15%)
Live price · Source: Yahoo
52-Week Position
$71.00
3% of range
$149.75
Beta
0.729
Low vol
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.729
52W High$149.75
52W Low$71.00
DipBuster Brief
Key signals at a glance
Zone: Strong Buy
Bullish
Near 52-Week Low — Wide Margin of Safety
At 3% of its annual range the stock is near its floor, offering value investors a cushion before fundamentals need to re-rate.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position3% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.729
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at Zoetis Inc. (ZTS), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-08-07 | Damelio Frank A | SELL | 6,650 |
| 2026-07-10 | Sarbaugh Keith | BUY | 260 |
| 2026-07-10 | Nayak Abhay U | BUY | 215 |
| 2026-07-10 | Esch Kevin | BUY | 308 |
| 2026-07-10 | Driscoll Rimma | BUY | 238 |
| 2026-07-10 | Fuller Julie | BUY | 315 |
| 2026-07-10 | Lagano Roxanne | BUY | 315 |
| 2026-07-10 | Ferran Astorga Jeannette | BUY | 45 |
| 2026-07-10 | Peck Kristin C | BUY | 616 |
| 2026-07-10 | Joseph Wetteny | BUY | 363 |
Valuation
P/E RatioN/A
Market CapN/A
Beta0.729
Dividend/yrNone
52W High$149.75
52W Low$71.00
52-Week Range
$71.00Now$149.75
3% through annual range
From 52W High−51.3%
From 52W Low+2.8%
📖 Plain English Summary
Zoetis Inc. is at 3% of its 52-week range. Beta 0.729 — tends to move less than the market.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for ZTS
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — ZTS
Heuristic · balance sheet, insider filings, price data, academic research
Zoetis Inc. — DipBuster Score 52/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track Zoetis Inc. free
Add ZTS to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Trading 212
Commission-free investing. ISA and GIA available. FCA regulated.
Free share worth up to £100 when you sign up
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
39/25
Momentum & Volume
8/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
60
/100 · STRONG
dip depth
25/25
oversold rsi
9/25
mean reversion
11/15
insider zone
15/25
capitulation
0/10
Insiders' avg buy price: $76.08 — marked 🟡 on the chart above.
Technical signal only. Not financial advice.
Quick Take
🟢
Dip Signal
DipBuster Score: 52/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfol…
Sector
Healthcare
Market
🇺🇸 US
CEO
Kristin C. Peck
Staff
14,500 employees
Website